<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03079414</url>
  </required_header>
  <id_info>
    <org_study_id>108939</org_study_id>
    <nct_id>NCT03079414</nct_id>
  </id_info>
  <brief_title>The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest</brief_title>
  <acronym>EPS ARREST</acronym>
  <official_title>The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Western University, Canada</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Academic Medical Organization of Southwestern Ontario</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Western University, Canada</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sudden cardiac death (SCD) remains a major cause of mortality within developed nations
      despite aggressive efforts to reduce its societal burden. Despite extensive clinical and
      genetic investigations, a subgroup of cardiac arrests remain unexplained, highlighting the
      potential contribution of additional cardiac conditions that may not be identified with
      contemporary diagnostic algorithms. The EPS ARREST study aims to evaluate the role of
      invasive electrophysiology study within this patient population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The majority of cases of SCD in older individuals occur secondary to coronary and structural
      heart disease, while genetic channelopathies and cardiomyopathies are prominent contributors
      in young adults. Among individuals that suffer aborted cardiac arrests in the absence of
      overt coronary and structural heart disease, diagnostic algorithms that screen for cardiac
      channelopathies and more subtle forms of structural heart disease have been established.
      Despite the extensive investigations currently utilized, a significant proportion of aborted
      cardiac arrests remain unexplained.

      Although invasive electrophysiology studies are a cornerstone for diagnosis and management of
      arrhythmia disorders, they are not invariably included in the workup of cases of unexplained
      aborted cardiac arrest. This is largely driven by initial studies suggesting that the
      diagnostic yield in this context is low, however these investigations often used invasive
      electrophysiology studies indiscriminately in all cases of aborted cardiac arrest. Since
      these earlier studies, our insight and approach to SCD has evolved and it has become clear
      that the majority of patients do not require an invasive electrophysiology study for
      diagnosis. However an invasive electrophysiology study may still have an important role among
      these individuals when the initial workup is negative. Notably, arrhythmias that require
      invasive electrophysiology for diagnosis, including bundle branch reentrant ventricular
      tachycardia and supraventricular tachycardias associated with hemodynamic collapse, have been
      identified as arrhythmic culprits in this patient population.

      The goal of the EPS ARREST study is to evaluate the diagnostic yield of a standardized
      invasive electrophysiology study among survivors of SCD when initial investigations fail to
      identify an underlying etiology.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Anticipated">May 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Arrhythmic culprit for aborted cardiac arrest</measure>
    <time_frame>Assessed immediately upon testing</time_frame>
    <description>Identification of an arrhythmic culprit for aborted cardiac arrest using an invasive electrophysiology study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of bundle branch reentrant ventricular tachycardia</measure>
    <time_frame>Assessed immediately upon testing</time_frame>
    <description>Prevalence of bundle branch reentrant ventricular tachycardia among survivors of unexplained cardiac arrest.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of supraventricular tachycardia associated with hemodynamic collapse</measure>
    <time_frame>Assessed immediately upon testing</time_frame>
    <description>Prevalence of inducible supraventricular tachycardia during invasive electrophysiology study among survivors of unexplained cardiac arrest.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of a latent/cryptic accessory pathway</measure>
    <time_frame>Assessed immediately upon testing.</time_frame>
    <description>Prevalence of a latent/cryptic accessory pathway among survivors of unexplained cardiac arrest.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Sudden Cardiac Death</condition>
  <arm_group>
    <arm_group_label>Unexplained Aborted Cardiac Arrest</arm_group_label>
    <description>Survivors of sudden cardiac death with no identifiable etiology following initial diagnostic workup.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Invasive Electrophysiology Study</intervention_name>
    <description>Invasive electrophysiology studies will be performed using four catheters placed in the right ventricular apex, the coronary sinus, the His bundle region, and the high right atrium. Standard induction protocols for supraventricular and ventricular arrhythmias will be utilized in the absence and presence of isoproterenol. Long-short ventricular extra-stimuli will also be delivered to screen for bundle branch reentrant ventricular tachycardia. The study is considered observational as the participating sites perform electrophysiology studies in this patient population as part of standard clinical care.</description>
    <arm_group_label>Unexplained Aborted Cardiac Arrest</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA will be collected on patients identified to possess bundle branch reentrant ventricular
      tachycardia on invasive electrophysiology study.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Survivors of unexplained sudden cardiac death for whom an underlying etiology remains
        unclear following a standard diagnostic workup, including 12-lead surface ECG, coronary
        artery assessment, echocardiography, cardiac MRI with late gadolinium enhancement,
        procainamide challenge, and exercise treadmill testing.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Unexplained cardiac arrest requiring cardioversion or defibrillation

          2. Willing and able to sign informed consent

        Exclusion Criteria:

          1. Coronary artery disease (stenosis &gt; 50%) and clinical findings consistent with an
             ischemic arrest

          2. Reduced left ventricular function (left ventricular ejection fraction &lt; 50%) on
             echocardiogram or cardiac MRI.

          3. Persistent resting QTc &gt; 460 msec for males and 480 msec for females

          4. Resting QTc &lt; 350 msec

          5. Type I Brugada ECG with &gt;/= 2 mm ST elevation in V1 and/or V2 (Spontaneous or
             Drug-Induced)

          6. Polymorphic or bidirectional ventricular tachycardia observed with exertion on
             exercise treadmill testing

          7. Clinical, electrocardiographic, and/or imaging findings consistent with a diagnosis of
             arrhythmogenic right ventricular cardiomyopathy

          8. Myocarditis

          9. Reversible cause of cardiac arrest such as marked hypokalemia (&lt;2.8 mmol/l) or drug
             overdose sufficient in severity without other cause to explain the cardiac arrest.

         10. Arrhythmic mitral valve prolapse syndrome

         11. Documented ventricular fibrillation initiated by a short-coupled premature ventricular
             contraction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jason D Roberts, MD MAS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Western University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrew D Krahn, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Melvin M Scheinman, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jason D Roberts, MD MAS</last_name>
    <phone>(519) 663-3746</phone>
    <phone_ext>34526</phone_ext>
    <email>jason.roberts@lhsc.on.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>UCLA Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jason S Bradfield, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UC San Diego Health System</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kurt S Hoffmayer, MD PharmD</last_name>
    </contact>
    <contact_backup>
      <last_name>Jonathan C Hsu, MD MAS</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>UCSF Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143-0124</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melvin M Scheinman, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marco V Perez, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Duy T Nguyen, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queen's Medical Center</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David K Singh, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Steven A Lubitz, MD MPH</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Regions Hospital</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dennis W Zhu, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Babak Nazer, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Thomas A Dewland, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Benjamin Shoemaker, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frederick T Han, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>British Columbia Children's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shubhayan Sanatani, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of British Columbia</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew D Krahn, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Zachary Laksman, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>QEII Health Sciences Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Gardner, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hamilton Health Sciences</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeff Healey, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason D Roberts, MD MAS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Toronto General Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael H Gollob, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Montreal Heart Institute</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafik Tadros, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Laval University</name>
      <address>
        <city>Quebec City</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Steinberg, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tel-Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel-Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raphael Rosso, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Sami Viskin, MD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Israel</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Krahn AD, Healey JS, Chauhan V, Birnie DH, Simpson CS, Champagne J, Gardner M, Sanatani S, Exner DV, Klein GJ, Yee R, Skanes AC, Gula LJ, Gollob MH. Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER). Circulation. 2009 Jul 28;120(4):278-85. doi: 10.1161/CIRCULATIONAHA.109.853143. Epub 2009 Jul 13. Erratum in: Circulation. 2010 Jun 29;121(25):e460.</citation>
    <PMID>19597050</PMID>
  </reference>
  <reference>
    <citation>Wang YS, Scheinman MM, Chien WW, Cohen TJ, Lesh MD, Griffin JC. Patients with supraventricular tachycardia presenting with aborted sudden death: incidence, mechanism and long-term follow-up. J Am Coll Cardiol. 1991 Dec;18(7):1711-9.</citation>
    <PMID>1960318</PMID>
  </reference>
  <reference>
    <citation>Roberts JD, Gollob MH, Young C, Connors SP, Gray C, Wilton SB, Green MS, Zhu DW, Hodgkinson KA, Poon A, Li Q, Orr N, Tang AS, Klein GJ, Wojciak J, Campagna J, Olgin JE, Badhwar N, Vedantham V, Marcus GM, Kwok PY, Deo RC, Scheinman MM. Bundle Branch Re-Entrant Ventricular Tachycardia: Novel Genetic Mechanisms in a Life-Threatening Arrhythmia. JACC Clin Electrophysiol. 2017 Mar;3(3):276-288. doi: 10.1016/j.jacep.2016.09.019. Epub 2016 Dec 21.</citation>
    <PMID>29759522</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2017</study_first_submitted>
  <study_first_submitted_qc>March 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 14, 2017</study_first_posted>
  <last_update_submitted>March 8, 2018</last_update_submitted>
  <last_update_submitted_qc>March 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sudden Cardiac Death</keyword>
  <keyword>Cardiac Arrhythmia</keyword>
  <keyword>Electrophysiology Study</keyword>
  <keyword>Genetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Death</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no current plan to share IPD with other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

